Omada (OMDA) Q2 2025 earnings

Omada Health reported quarterly results for the primary time since its initial public offering in June.

Here’s how the corporate did based on average analysts’ estimates compiled by LSEG:

• Loss per share: 24 cents
• Revenue: $61 million vs. $55.2 million expected

The virtual care company’s revenue increased 49% in its second quarter from $41.21 million a 12 months earlier. The corporate reported a net lack of $5.31 million, or a lack of 24 cents per share, in comparison with a net lack of $10.69 million, or a lack of $1.40 per share, through the same period last 12 months.

“It is a strategically consistent quarter for Omada, happening at an accelerated pace, which is sweet,” Omada CEO Sean Duffy said in an interview with CNBC. “At the best levels, there’s just an enormous highlight on metabolic care straight away.”

For its full 12 months, Omada expects to report revenue between $235 million and $241 million, while analysts were expecting $222 million. The corporate said it expects to report an adjusted earnings before interest, taxes, depreciation and amortization, or EBITDA, lack of $9 million to $5 million for the total 12 months, while analysts polled by FactSet expected a wider lack of $20.2 million.

Omada, founded in 2011, offers virtual care programs to support patients with chronic conditions similar to prediabetes, diabetes and hypertension. The corporate describes its approach as a “between-visit care model” that’s complementary to the broader health-care ecosystem.

The stock opened at $23 in its debut on the Nasdaq in June. At market close on Thursday, shares closed at $19.46.

Omada said it finished its second quarter with 752,000 total members, up 52% 12 months over 12 months.

“The beginning gun of our next chapter just clicked, and we’re running hard,” Duffy said. “It has been pretty fun.”

CORRECTION: This text was updated to state that Omada Health was founded in 2011. A previous version incorrectly stated the 12 months.